Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Attention-deficit/hyperactivity disorder and substance abuse.

Literature DB >> 24982106

Attention-deficit/hyperactivity disorder and substance abuse.

Abstract

Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.

Entities: Disease Species

Keywords: ADHD; attention-deficit/hyperactivity disorder; nonstimulant medication; safe prescribing; stimulant medication; substance abuse

Mesh：

Substances：

Year: 2014 PMID： 24982106 DOI： 10.1542/peds.2014-0992

Source DB: PubMed Journal: Pediatrics ISSN： 0031-4005 Impact factor: 7.124

Keyword Cloud
Cited

21 in total

1. Pharmacotherapy for Substance Use Disorders in Youths.

Authors: Christopher J Hammond; Kevin M Gray
Journal: J Child Adolesc Subst Abuse Date: 2016-04-20

2. Early-life risperidone enhances locomotor responses to amphetamine during adulthood.

Authors: Bobbie Lee Stubbeman; Clifford J Brown; Justin R Yates; Mark E Bardgett
Journal: Eur J Pharmacol Date: 2017-07-14 Impact factor: 4.432

3. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Authors: Mark L Wolraich; Joseph F Hagan; Carla Allan; Eugenia Chan; Dale Davison; Marian Earls; Steven W Evans; Susan K Flinn; Tanya Froehlich; Jennifer Frost; Joseph R Holbrook; Christoph Ulrich Lehmann; Herschel Robert Lessin; Kymika Okechukwu; Karen L Pierce; Jonathan D Winner; William Zurhellen
Journal: Pediatrics Date: 2019-10 Impact factor: 7.124

4. Distance-Learning, ADHD Quality Improvement in Primary Care: A Cluster-Randomized Trial.

Authors: Alexander G Fiks; Stephanie L Mayne; Jeremy J Michel; Jeffrey Miller; Manju Abraham; Andrew Suh; Abbas F Jawad; James P Guevara; Robert W Grundmeier; Nathan J Blum; Thomas J Power
Journal: J Dev Behav Pediatr Date: 2017-10 Impact factor: 2.225

5. Adolescent and Parent Management of Controlled Prescription Medications.

Authors: Stacey A Engster; Debra L Bogen; Brooke S G Molina
Journal: Subst Use Misuse Date: 2019-07-29 Impact factor: 2.164

6. Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.

Authors: Jeanne M Madden; Matthew D Lakoma; Frances L Lynch; Donna Rusinak; Ashli A Owen-Smith; Karen J Coleman; Virginia P Quinn; Vincent M Yau; Yinge X Qian; Lisa A Croen
Journal: J Autism Dev Disord Date: 2017-01

7. Association of Risk of Suicide Attempts With Methylphenidate Treatment.

Authors: Kenneth K C Man; David Coghill; Esther W Chan; Wallis C Y Lau; Chris Hollis; Elizabeth Liddle; Tobias Banaschewski; Suzanne McCarthy; Antje Neubert; Kapil Sayal; Patrick Ip; Martijn J Schuemie; Miriam C J M Sturkenboom; Edmund Sonuga-Barke; Jan Buitelaar; Sara Carucci; Alessandro Zuddas; Hanna Kovshoff; Peter Garas; Peter Nagy; Sarah K Inglis; Kerstin Konrad; Alexander Häge; Eric Rosenthal; Ian C K Wong
Journal: JAMA Psychiatry Date: 2017-10-01 Impact factor: 21.596